AAstraZeneca Read More New FDA Nod Keeps Gilead Drug Competitive With AstraZeneca & Daiichi in Breast CancerJune 25, 2026 The FDA has expanded the approval of a targeted Gilead Sciences therapy as a new first-line treatment for…
GGSK Read More The Zacks Analyst Blog Highlights Gilead Sciences, Merck and GSKJune 17, 2026 For Immediate Release Chicago, IL – June 17, 2026 – Zacks.com announces the list of stocks featured in…